TEKNOFEST Oncology 3T Competition

Cancer continues to be a significant public health issue within global healthcare systems. Advances documented in medical research have enabled the development of various methods for diagnosis and treatment. Alongside traditional therapeutic approaches, personalized medicine practices based on individual genetic profiles and tumor characteristics are increasingly coming to the fore.

In this context, developments in fields such as genetic engineering, biotechnology, and artificial intelligence are contributing to the shaping of next-generation treatment strategies. Within this framework, the TEKNOFEST 2025 3T Competition in Oncology aims to encourage researchers to develop innovative treatment methods focused on lung cancer.

Scope of the Competition

Cancer can follow different courses among individuals, and patients with the same diagnosis may respond differently to similar treatment protocols. Consequently, cancer research is increasingly shifting toward personalized treatment approaches. Among the prominent technological and scientific methods in this area are CRISPR-based gene editing, immunotherapy applications, artificial intelligence-assisted drug development processes, and therapeutic cancer vaccines. The 3T Competition in Oncology, held within TEKNOFEST 2025, promotes multidisciplinary approaches and encourages young researchers to develop solutions specifically focused on lung cancer.

Project Titles

1. Genetic and Epigenetic Approaches: Can genetic mutations leading to lung cancer be corrected using CRISPR and similar gene-editing techniques?

2. Cellular and Molecular Therapies: How can immunotherapy, smart drugs, tumor-targeted antibodies, CAR-T cell therapies, and transgenic NK (Natural Killer) cells be deployed in the fight against cancer?

3. Artificial Intelligence-Assisted Drug Development: Can artificial intelligence accelerate the development of personalized drugs? How can the identification of cancer-specific targets be optimized?

4. Therapeutic Cancer Vaccine Technologies: How can RNA- and DNA-based cancer vaccines strengthen the immune system against cancer?

Eligibility Criteria

The competition offers a platform for undergraduate, master’s, and doctoral students to apply as teams. Doctoral graduates may participate only as advisors. Teams must consist of at least three and no more than five members, and must present their projects within a scientific framework.

Significance of the Competition

Scientific research in oncology enables the development of new treatment methods, and interdisciplinary collaboration has become increasingly vital in this process. The TEKNOFEST 3T Competition in Oncology aims to promote scientific productivity among young researchers and contribute to the advancement of applications for cancer treatment. The competition also serves as a scientific platform that highlights the role of technology and biomedical research in the fight against cancer.